| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.68B | 23.11B | 19.40B | 18.90B | 17.82B | 15.36B |
| Gross Profit | 3.52B | 7.33B | 3.77B | 3.88B | 3.07B | 2.58B |
| EBITDA | 2.58B | 6.13B | 3.05B | 3.27B | 2.45B | 1.70B |
| Net Income | 1.16B | 3.86B | 2.18B | 1.66B | 745.00M | 1.19B |
Balance Sheet | ||||||
| Total Assets | 16.21B | 23.40B | 19.33B | 17.88B | 16.95B | 15.66B |
| Cash, Cash Equivalents and Short-Term Investments | 2.50B | 7.30B | 4.19B | 3.90B | 2.53B | 1.85B |
| Total Debt | 3.07B | 1.13B | 1.45B | 1.95B | 1.78B | 2.53B |
| Total Liabilities | 6.31B | 5.88B | 5.17B | 5.56B | 6.20B | 5.51B |
| Stockholders Equity | 9.90B | 17.52B | 14.15B | 12.32B | 10.75B | 10.15B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.08B | 1.09B | 2.14B | 599.00M | 993.84M |
| Operating Cash Flow | 0.00 | 6.09B | 3.22B | 3.38B | 2.52B | 1.84B |
| Investing Cash Flow | 0.00 | -2.06B | -2.26B | -1.28B | -1.82B | -784.90M |
| Financing Cash Flow | 0.00 | -911.00M | -663.00M | -722.00M | -19.00M | -961.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥18.43B | 6.13 | ― | 2.45% | 19.13% | 77.08% | |
75 Outperform | ¥60.10B | 8.50 | ― | 2.44% | 3.38% | 57.67% | |
70 Outperform | ¥65.54B | 19.80 | ― | 3.98% | 0.60% | -6.50% | |
69 Neutral | ¥176.80B | 27.33 | ― | 1.65% | 3.99% | -42.24% | |
63 Neutral | ¥69.85B | 22.50 | ― | 0.34% | 10.22% | 13.91% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | ¥89.31B | 10.54 | ― | 3.59% | 6.25% | 246.08% |